What is ASBP’s calculated intrinsic value vs its market price?
Aspire Biopharma Holdings, Inc. (ASBP) current market price is $9.21. Tickerplace Pro unlocks the dollar intrinsic value estimate. This is a model output, not a recommendation.
Search companies or stocks...
Aspire Biopharma Holdings, Inc. (ASBP) valuation snapshot is loading. Our models compare market price to fair value using DCF, P/E, and P/S frameworks.
Confidence score is based on the magnitude of the gap vs the modeled estimate.
Fair value estimate
Unlock fair valueCurrent price
$9.21
Intrinsic value for Aspire Biopharma Holdings, Inc. (ASBP) is estimated from cash flows, growth, reinvestment, and a risk-adjusted discount rate, then compared with the current market price.
A second lens is historical valuation: today’s multiple versus the company’s own five-year average. That comparison describes where the multiple sits relative to past ranges — it is not a buy or sell conclusion.
Market price also embeds assumptions about revenue, margins, and capital returns. Use the ratios and financials linked on this page to see the inputs behind the calculated gap.
Aspire Biopharma Holdings, Inc. (ASBP) current market price is $9.21. Tickerplace Pro unlocks the dollar intrinsic value estimate. This is a model output, not a recommendation.
Intrinsic value is an estimate of what ASBP shares may be worth based on fundamentals rather than today's price alone. See the valuation snapshot on this page for the latest model output. Tickerplace Pro unlocks the full dollar fair value estimate.
Tickerplace calculates ASBP's fair value using Discounted Cash Flow (DCF), P/E Multiple, and P/S Multiple models. We compare the resulting intrinsic value estimate to the live market price to show the calculated gap.
The fair value gap is the percentage difference between ASBP’s market price and the modeled fair value estimate. Use it as one research input alongside fundamentals — not as a recommendation.
Peers for ASBP: open their calculated fair value vs price view.